In recent years, COX-2 inhibitors have been widely used in the treatment of depressed patients, and the drugs commonly used in clinical practice as COX-2 inhibitors are non-steroidal anti-inflammatory drugs (NSAIDs), all of which have varying degrees of efficacy in depression (111–113). This evidence concerns the gene PTGS2 and depressive symptom measurement.